Skip to main content

UFP Technologies Inc (UFPT)

Other Materials Basic Materials
Stock AI

Financial Metrics

Price to Earnings34.55x
Revenue Growth (1Y)7.32%
Debt to Equity0.25x

Strengths

Stock Chart

Valuation

UFP Technologies Inc is overvalued

News

All
Press Releases
News
Filings
10-Q Quarterly Report for 2026 Q2
August 06, 202610-Q Quarterly Report for 2026 Q2
UFP Technologies Announces Record Q2 Results
August 03, 2026UFP Technologies Announces Record Q2 Results
UFP Technologies to Report Second Quarter 2026 Financial Results on August 3, 2026
July 29, 2026UFP Technologies to Report Second Quarter 2026 Financial Results on August 3, 2026
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the CJS Securities 26th Annual New Ideas Summer Conference
July 01, 2026UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the CJS Securities 26th Annual New Ideas Summer Conference
UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10th in New York, NY
June 04, 2026UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10th in New York, NY
UFP Technologies Names Ryan Stafford General Counsel and Senior Vice President of Human Resources
June 04, 2026UFP Technologies Names Ryan Stafford General Counsel and Senior Vice President of Human Resources
10-Q Quarterly Report for 2026 Q1
May 08, 202610-Q Quarterly Report for 2026 Q1
UFP Technologies Announces Strong Q1 Results
May 04, 2026UFP Technologies Announces Strong Q1 Results
UFP Technologies to Report First Quarter 2026 Financial Results on May 4, 2026
April 30, 2026UFP Technologies to Report First Quarter 2026 Financial Results on May 4, 2026
UFP Technologies to Present and Host 1X1 Investor Meetings at the KeyBanc Capital Markets Virtual Healthcare Forum
March 17, 2026UFP Technologies to Present and Host 1X1 Investor Meetings at the KeyBanc Capital Markets Virtual Healthcare Forum
UFP Technologies to Present and Host 1X1 Investor Meetings at the Raymond James 47th Annual Institutional Investors Conference
February 27, 2026UFP Technologies to Present and Host 1X1 Investor Meetings at the Raymond James 47th Annual Institutional Investors Conference
10-K Annual Report for 2025 FY
February 27, 202610-K Annual Report for 2025 FY
UFP Technologies Announces Record 2025 Results
February 24, 2026UFP Technologies Announces Record 2025 Results
UFP Technologies to Report Fourth Quarter and Year-End 2025 Financial Results on February 24, 2026
February 19, 2026UFP Technologies to Report Fourth Quarter and Year-End 2025 Financial Results on February 24, 2026
UFP Technologies Announces CEO Succession Plan
December 02, 2025UFP Technologies Announces CEO Succession Plan
UFP Technologies to Present and Host 1X1 Investor Meetings at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025UFP Technologies to Present and Host 1X1 Investor Meetings at the Piper Sandler 37th Annual Healthcare Conference
10-Q Quarterly Report for 2025 Q3
November 07, 202510-Q Quarterly Report for 2025 Q3
UFP Technologies Announces Strong Q3 2025 Results
November 03, 2025UFP Technologies Announces Strong Q3 2025 Results
UFP Technologies to Report Third Quarter 2025 Financial Results on November 3, 2025
October 29, 2025UFP Technologies to Report Third Quarter 2025 Financial Results on November 3, 2025
UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL
August 20, 2025UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL
10-Q Quarterly Report for 2025 Q2
August 11, 202510-Q Quarterly Report for 2025 Q2
UFP Technologies Announces Record Q2 Results
August 04, 2025UFP Technologies Announces Record Q2 Results
UFP Technologies to Report Second Quarter 2025 Financial Results on August 4, 2025
July 29, 2025UFP Technologies to Report Second Quarter 2025 Financial Results on August 4, 2025
UFP Technologies Acquires UNIPEC and TPI to Expand Film and Thermoplastic Molding Capabilities
July 17, 2025UFP Technologies Acquires UNIPEC and TPI to Expand Film and Thermoplastic Molding Capabilities
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the CJS Securities 25th Annual Summer Conference
July 08, 2025UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the CJS Securities 25th Annual Summer Conference
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Goldman Sachs 46th Annual Global Healthcare Conference
UFP Technologies to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast IDEAS Investor Conference on June 11th in New York, NY
June 03, 2025UFP Technologies to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast IDEAS Investor Conference on June 11th in New York, NY
Sell Alert: Christopher P Litterio Cashes Out $324K In UFP Technologies Stock
May 13, 2025Sell Alert: Christopher P Litterio Cashes Out $324K In UFP Technologies Stock
10-Q Quarterly Report for 2025 Q1
May 12, 202510-Q Quarterly Report for 2025 Q1
UFP Technologies to Report First Quarter 2025 Financial Results on May 6, 2025
April 30, 2025UFP Technologies to Report First Quarter 2025 Financial Results on May 6, 2025
UFP Technologies to Present and Host Investor Meetings at the KeyBanc Capital Healthcare Forum
March 17, 2025UFP Technologies to Present and Host Investor Meetings at the KeyBanc Capital Healthcare Forum
Insider Transaction: Daniel C Croteau Sells $1.56M Worth Of UFP Techs Shares
March 04, 2025Insider Transaction: Daniel C Croteau Sells $1.56M Worth Of UFP Techs Shares
10-K Annual Report for 2024 FY
March 03, 202510-K Annual Report for 2024 FY
UFP Technologies Announces Record 2024 Results
February 25, 2025UFP Technologies Announces Record 2024 Results
UFP Technologies to Report Fourth Quarter and Year-end 2024 Results on February 25, 2025
February 19, 2025UFP Technologies to Report Fourth Quarter and Year-end 2024 Results on February 25, 2025
UFP Technologies to Present and Host 1X1 Investor Meetings at the CJS Securities 25th Annual “New Ideas for the New Year” Virtual Conference
January 10, 2025UFP Technologies to Present and Host 1X1 Investor Meetings at the CJS Securities 25th Annual “New Ideas for the New Year” Virtual Conference
10-Q Quarterly Report for 2024 Q3
November 12, 202410-Q Quarterly Report for 2024 Q3
UFP Technologies Announces Record Q3 2024 Results
November 05, 2024UFP Technologies Announces Record Q3 2024 Results
UFP Technologies Acquires AQF Medical
August 26, 2024UFP Technologies Acquires AQF Medical
UFP Technologies to Present and Host 1x1 Investor Meetings at the 15th Annual Midwest IDEAS Investor Conference on August 28th & 29th in Chicago, IL
August 26, 2024UFP Technologies to Present and Host 1x1 Investor Meetings at the 15th Annual Midwest IDEAS Investor Conference on August 28th & 29th in Chicago, IL
10-Q Quarterly Report for 2024 Q2
August 09, 202410-Q Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q1
May 10, 202410-Q Quarterly Report for 2024 Q1
10-K Annual Report for 2023 FY
February 29, 202410-K Annual Report for 2023 FY
10-Q Quarterly Report for 2023 Q3
November 09, 202310-Q Quarterly Report for 2023 Q3
10-Q Quarterly Report for 2023 Q2
August 09, 202310-Q Quarterly Report for 2023 Q2
10-Q Quarterly Report for 2023 Q1
May 10, 202310-Q Quarterly Report for 2023 Q1
10-K Annual Report for 2022 FY
March 16, 202310-K Annual Report for 2022 FY
10-Q/A Quarterly Report for 2022 Q3
November 14, 202210-Q/A Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q3
November 09, 202210-Q Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q2
August 09, 202210-Q Quarterly Report for 2022 Q2
10-Q Quarterly Report for 2022 Q1
May 10, 202210-Q Quarterly Report for 2022 Q1
10-K Annual Report for 2021 FY
March 14, 202210-K Annual Report for 2021 FY
10-Q Quarterly Report for 2021 Q3
November 05, 202110-Q Quarterly Report for 2021 Q3

A. Company Overview

UFP Technologies Inc. is a designer and custom manufacturer recognized for providing comprehensive solutions for a range of specialized markets, most notably in medical devices and highly engineered custom products. Established in Delaware in 1993, the company has grown to become a significant player in the medical device supply chain, serving many of the leading manufacturers in the sector. With a diversified product range that includes single-use and single-patient devices and components, UFP Technologies focuses on various applications that span minimally invasive surgery, infection prevention, wound care, wearables, and orthopedic products, among others.

In addition to its medical device offerings, the company also caters to the automotive, aerospace and defense, and industrial markets. Its product applications in these sectors include components for military uniforms and gear, automotive interior trim, air filtration systems, and protective cases. The company's robust operational capabilities have enabled it to establish a strong foothold in diverse industries while maintaining a commitment to high-quality engineering.

B. Market Overview

The applications for UFP Technologies’ products are extensive and targeted towards specific macro-market trends. The medical technology (MedTech) sector is the company’s primary focus, leveraging specialty materials and deep engineering expertise to meet and anticipate customer needs in niche markets. With a commitment to innovation, the company continuously explores new design methodologies and materials to stay ahead in a competitive landscape.

C. Products

UFP Technologies specializes in custom products that cater to a variety of market demands. The company’s manufacturing options encompass an array of processes such as cutting, routing, compression and injection molding, vacuum forming, laminating, radio frequency welding, impulse welding, and assembly.

For the medical field, products are designed and prototyped through collaboration between engineering personnel and clients. These prototypes are refined into final designs that fulfill the specific requirements of commercial production runs. Notable manufacturing capabilities include the production of molded cross-linked foam products and thermoplastic welded devices, utilizing advanced techniques like thermoforming and cutting systems that allow for high precision.

In the automotive sector, UFP Technologies engineers components that serve various functions, utilizing a compression molding process to create functional composites from materials such as polypropylene and fiberglass. The company also fabricates filtration and insulation products through specialized cutting methods, ensuring versatility in product application.

D. Regulatory Climate and Environmental Considerations

UFP Technologies operates in a highly regulated environment, particularly within its medical segment, where adherence to FDA approval and the ISO 13485 quality standards is requisite. The company has established eleven manufacturing facilities with ISO 13485 certification and eight that are FDA registered, underscoring its commitment to regulatory compliance.

Environmental considerations form a key aspect of the operational framework, with the company striving to innovate and design products that achieve optimum performance while minimizing material usage. With facilities employing various sustainable practices, such as solar power utilization and recycling initiatives, UFP Technologies is poised to respond to market trends favoring environmentally responsible manufacturing.

E. Manufacturing

The manufacturing operations at UFP Technologies are centered on precision-driven processes that align with customer-specific performance needs. Skilled personnel are dedicated to analyzing customer requirements and developing tailored prototypes, facilitating rapid conversion into mass production. The company’s capabilities encompass a broad spectrum of techniques, including advanced molding processes and assembly techniques that integrate foam with other materials.

The company does not manufacture raw materials but sources them from a number of reliable suppliers, emphasizing strong relationships to ensure a consistent supply chain, particularly for specialized materials like cross-linked and technical polyurethane foams.

F. Research and Development

Research and development constitute crucial components of UFP Technologies’ strategy, driving the exploration of new materials, manufacturing techniques, and product designs. The engineering team is committed to innovation, continuously identifying opportunities to enhance product performance and operational efficiency. R&D efforts support the development of products that meet stringent industry specifications while accommodating unique client requirements.

G. Competition

The landscape within the medical design and contract manufacturing sector is characterized by intense competition, particularly from smaller independent firms that often focus on specific geographic regions or industries. UFP Technologies distinguishes itself by blending its comprehensive engineering capabilities with a wide variety of material choices and a customer-centric approach. The company maintains a competitive edge through its established relationships with key material suppliers and a dedication to meeting preferred vendor requirements.

H. Patents and Proprietary Rights

UFP Technologies actively protects its innovations through a combination of trade secrets, patents, and trademarks. The company holds a total of 19 active patents related directly to various technologies, including those relevant to foam products, automated manufacturing processes, and packaging solutions. While patents provide legal protection, the company also relies heavily on proprietary know-how and continuous improvement initiatives to maintain its competitive advantages in the marketplace.

Stock Infos

SectorBasic Materials
IndustryOther Materials
CEOR. Jeffrey Bailly

Dividends

Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.